ORMP
Oramed Pharmaceuticals Inc
Price:  
2.25 
USD
Volume:  
89,632.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORMP Relative Valuation

-2.9%
Upside

As of 2024-06-17, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 2.19 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.25 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is -2.9%.

The range of the Relative Valuation is 1.66 - 3.48 USD.

Range Selected
Trailing P/E multiples 8.9x - 13.5x 9.1x
Forward P/E multiples 23.2x - 28.5x 28.3x
Fair Price 1.66 - 3.48 2.19
Upside -26.1% - 54.5% -2.9%
2.25 USD
Stock Price
2.19 USD
Fair Price

ORMP Relative Valuation - Historical P/E Data

Date P/E
2024-06-14 8.74
2024-06-13 8.87
2024-06-12 9.05
2024-06-11 8.04
2024-06-10 8.27
2024-06-07 8.16
2024-06-06 8.47
2024-06-05 8.58
2024-06-04 8.39
2024-06-03 8.58
2024-05-31 8.47
2024-05-30 8.70
2024-05-29 8.47
2024-05-28 8.54
2024-05-24 9.09
2024-05-23 9.01
2024-05-22 8.93
2024-05-21 8.97
2024-05-20 9.20
2024-05-17 8.93
2024-05-16 9.05
2024-05-15 9.28
2024-05-14 9.59
2024-05-13 9.36
2024-05-10 9.30
2024-05-09 9.24
2024-05-08 9.44
2024-05-07 9.32
2024-05-06 9.67
2024-05-03 9.13
2024-05-02 9.09
2024-05-01 9.09
2024-04-30 9.01
2024-04-29 9.46
2024-04-26 9.55
2024-04-25 8.93
2024-04-24 9.20
2024-04-23 9.13
2024-04-22 9.05
2024-04-19 8.82
2024-04-18 8.54
2024-04-17 9.05
2024-04-16 9.32
2024-04-15 9.40
2024-04-12 9.79
2024-04-11 10.02
2024-04-10 10.33
2024-04-09 10.45
2024-04-08 10.76
2024-04-05 10.14